First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC

Lettmaier S, Hecht M, Fietkau R (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S73-S73

Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE

Event location: Munster DE

Authors with CRIS profile

How to cite

APA:

Lettmaier, S., Hecht, M., & Fietkau, R. (2019). First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S73-S73). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Lettmaier, S., Markus Hecht, and Rainer Fietkau. "First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC." Proceedings of the 25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO), Munster HEIDELBERG: SPRINGER HEIDELBERG, 2019. S73-S73.

BibTeX: Download